{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T21:44:18Z","timestamp":1774734258187,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01-NS057395"],"award-info":[{"award-number":["R01-NS057395"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01-AG020241"],"award-info":[{"award-number":["R01-AG020241"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01-NS050895"],"award-info":[{"award-number":["R01-NS050895"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003750","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["IIRG 12-239626"],"award-info":[{"award-number":["IIRG 12-239626"]}],"id":[{"id":"10.13039\/501100003750","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003750","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["NIRG 13-281227"],"award-info":[{"award-number":["NIRG 13-281227"]}],"id":[{"id":"10.13039\/501100003750","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Center for Research on Influenza Pathogenesis","award":["HHSN266200700010C"],"award-info":[{"award-number":["HHSN266200700010C"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.jneuroim.2014.10.002","type":"journal-article","created":{"date-parts":[[2014,10,16]],"date-time":"2014-10-16T14:07:17Z","timestamp":1413468437000},"page":"77-84","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["A dual vaccine against influenza & Alzheimer's disease failed to enhance anti-\u03b2-amyloid antibody responses in mice with pre-existing virus specific memory"],"prefix":"10.1016","volume":"277","author":[{"given":"Hayk","family":"Davtyan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anahit","family":"Ghochikyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armine","family":"Hovakimyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arpine","family":"Davtyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Cadagan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annette M.","family":"Marleau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randy A.","family":"Albrecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adolfo","family":"Garc\u00eda-Sastre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael G.","family":"Agadjanyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2014.10.002_bb0105","unstructured":"AC IMMUNE, Clinical Pipeline. http:\/\/www.acimmune.com\/content\/?p=41."},{"key":"10.1016\/j.jneuroim.2014.10.002_bb0010","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.4049\/jimmunol.174.3.1580","article-title":"Prototype Alzheimer's disease vaccine using the immunodominant B cell epitope from beta-amyloid and promiscuous T cell epitope pan HLA DR-binding peptide","volume":"174","author":"Agadjanyan","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2014.10.002_bb0200","article-title":"Active and passive A\u03b2-immunotherapy: positive and negative outcomes from pre-clinical and clinical trials and future directions","volume":"8","author":"Agadjanyan","year":"2009","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.jneuroim.2014.10.002_bb0015","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2174\/1573395054065179","article-title":"Immunotherapy for Alzheimer's disease: potential problems and possible solutions","volume":"1","author":"Cribbs","year":"2005","journal-title":"Curr. Immunol. Rev."},{"key":"10.1016\/j.jneuroim.2014.10.002_bb0020","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/intimm\/dxg049","article-title":"Adjuvant-dependent modulation of Th1 and Th2 responses to immunization with beta-amyloid","volume":"15","author":"Cribbs","year":"2003","journal-title":"Int. Immunol."},{"key":"10.1016\/j.jneuroim.2014.10.002_bb0040","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/gt.2009.140","article-title":"DNA prime-protein boost increased the titer, avidity and persistence of anti-Abeta antibodies in wild-type mice","volume":"17","author":"Davtyan","year":"2010","journal-title":"Gene Ther."},{"key":"10.1016\/j.jneuroim.2014.10.002_bb0025","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/1479-5876-9-127","article-title":"The immunological potency and therapeutic potential of a prototype dual vaccine against influenza and Alzheimer's disease","volume":"9","author":"Davtyan","year":"2011","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.jneuroim.2014.10.002_bb0035","doi-asserted-by":"crossref","first-page":"4923","DOI":"10.1523\/JNEUROSCI.4672-12.2013","article-title":"Immunogenicity, efficacy, safety, and mechanism of action of epitope vaccine (Lu AF20513) for Alzheimer's disease: prelude to a clinical trial","volume":"33","author":"Davtyan","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2014.10.002_bb0030","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jalz.2013.12.003","article-title":"The MultiTEP platform-based Alzheimer's disease epitope vaccine activates a broad repertoire of T helper cells in nonhuman primates","volume":"10","author":"Davtyan","year":"2014","journal-title":"Alzheimers Dement."},{"issue":"Suppl. 1","key":"10.1016\/j.jneuroim.2014.10.002_bb0045","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1471-4159.2011.07458.x","article-title":"\u2018Clinical trials in Alzheimer's disease\u2019: immunotherapy approaches","volume":"120","author":"Delrieu","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jneuroim.2014.10.002_bb0050","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jalz.2013.04.505","article-title":"Epitope-based DNA vaccine for Alzheimer's disease: translational study in macaques","volume":"10","author":"Evans","year":"2014","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.jneuroim.2014.10.002_bb0055","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1750-3639.2004.tb00493.x","article-title":"Neuropathology and pathogenesis of encephalitis following amyloid-beta immunization in Alzheimer's disease","volume":"14","author":"Ferrer","year":"2004","journal-title":"Brain Pathol."},{"key":"10.1016\/j.jneuroim.2014.10.002_bb0070","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1016\/j.vaccine.2005.11.039","article-title":"Prototype Alzheimer's disease epitope vaccine induced strong Th2-type anti-Abeta antibody response with Alum to Quil A adjuvant switch","volume":"24","author":"Ghochikyan","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.jneuroim.2014.10.002_bb0065","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.4161\/hv.23875","article-title":"Refinement of a DNA based Alzheimer's disease epitope vaccine in rabbits","volume":"9","author":"Ghochikyan","year":"2013","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.jneuroim.2014.10.002_bb0060","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s10585-013-9619-0","article-title":"Primary 4T1 tumor resection provides critical \u201cwindow of opportunity\u201d for immunotherapy","volume":"31","author":"Ghochikyan","year":"2014","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.jneuroim.2014.10.002_bb0075","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1212\/01.WNL.0000159740.16984.3C","article-title":"Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial","volume":"64","author":"Gilman","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2014.10.002_bb0080","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0264-410X(98)00274-6","article-title":"Enhanced CD8+ T cell response to HIV-1 env by combined immunization with influenza and vaccinia virus recombinants","volume":"17","author":"Gonzalo","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.jneuroim.2014.10.002_bb0085","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1111\/j.1476-5381.2011.01713.x","article-title":"Tau-targeted treatment strategies in Alzheimer's disease","volume":"165","author":"Gotz","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jneuroim.2014.10.002_bb0090","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/285664a0","article-title":"Carrier-priming leads to hapten-specific suppression","volume":"285","author":"Herzenberg","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2014.10.002_bb0095","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1084\/jem.155.6.1730","article-title":"Epitope-specific regulation. I. Carrier-specific induction of suppression for IgG anti-hapten antibody responses","volume":"155","author":"Herzenberg","year":"1982","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2014.10.002_bb0100","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0140-6736(08)61075-2","article-title":"Long-term effects of Abeta42 immunization in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial","volume":"372","author":"Holmes","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2014.10.002_bb0110","doi-asserted-by":"crossref","first-page":"5503","DOI":"10.1016\/j.vaccine.2010.02.103","article-title":"Carrier induced epitopic suppression of antibody responses induced by virus-like particles is a dynamic phenomenon caused by carrier-specific antibodies","volume":"28","author":"Jegerlehner","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.jneuroim.2014.10.002_bb0115","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.4049\/jimmunol.0900398","article-title":"Original antigenic sin responses to influenza viruses","volume":"183","author":"Kim","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2014.10.002_bb0120","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrneurol.2009.219","article-title":"Can Alzheimer disease be prevented by amyloid-beta immunotherapy?","volume":"6","author":"Lemere","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jneuroim.2014.10.002_bb0125","first-page":"628070","article-title":"Targeting Beta amyloid: a clinical review of immunotherapeutic approaches in Alzheimer's disease","volume":"2012","author":"Lobello","year":"2012","journal-title":"Int. J. Alzheimers Dis."},{"key":"10.1016\/j.jneuroim.2014.10.002_bb0130","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1371\/journal.pone.0002124","article-title":"Reducing AD-like pathology in 3xTg-AD mouse model by DNA epitope vaccine \u2014 a novel immunotherapeutic strategy","volume":"3","author":"Movsesyan","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2014.10.002_bb0135","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nm840","article-title":"Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report","volume":"9","author":"Nicoll","year":"2003","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.jneuroim.2014.10.002_bb0140","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1212\/01.WNL.0000073623.84147.A8","article-title":"Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization","volume":"61","author":"Orgogozo","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2014.10.002_bb0145","doi-asserted-by":"crossref","first-page":"12721","DOI":"10.1523\/JNEUROSCI.3201-07.2007","article-title":"Alzheimer's disease peptide epitope vaccine reduces insoluble but not soluble\/oligomeric A{beta} species in amyloid precursor protein transgenic mice","volume":"27","author":"Petrushina","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2014.10.002_bb0150","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.vaccine.2014.01.047","article-title":"Carrier priming or suppression: understanding carrier priming enhancement of anti-polysaccharide antibody response to conjugate vaccines","volume":"32","author":"Pobre","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.jneuroim.2014.10.002_bb0155","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1146\/annurev.med.45.1.435","article-title":"Cellular and molecular biology of Alzheimer's disease and animal models","volume":"45","author":"Price","year":"1994","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.jneuroim.2014.10.002_bb0160","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.coi.2004.07.012","article-title":"Current progress in beta-amyloid immunotherapy","volume":"16","author":"Schenk","year":"2004","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jneuroim.2014.10.002_bb0165","doi-asserted-by":"crossref","first-page":"446","DOI":"10.2174\/156720509789207930","article-title":"Tau-focused immunotherapy for Alzheimer's disease and related tauopathies","volume":"6","author":"Sigurdsson","year":"2009","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.jneuroim.2014.10.002_bb0170","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.expneurol.2010.10.007","article-title":"Recent advances in the development of immunotherapies for tauopathies","volume":"230","author":"Ubhi","year":"2011","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.jneuroim.2014.10.002_bb0175","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1084\/jem.140.6.1571","article-title":"Antibody responses to antigenic determinants of influenza virus hemagglutinin. II. Original antigenic sin: a bone marrow-derived lymphocyte memory phenomenon modulated by thymus-derived lymphocytes","volume":"140","author":"Virelizier","year":"1974","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2014.10.002_bb0180","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4049\/jimmunol.97.2.177","article-title":"Original antigenic sin in ferrets: the response to sequential infections with influenza viruses","volume":"97","author":"Webster","year":"1966","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2014.10.002_bb0185","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/nri1843","article-title":"Immunology and immunotherapy of Alzheimer's disease","volume":"6","author":"Weiner","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2014.10.002_bb0190","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(08)70170-4","article-title":"Amyloid-beta immunisation for Alzheimer's disease","volume":"7","author":"Wisniewski","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2014.10.002_bb0195","first-page":"6972","article-title":"Antitumor properties of influenza virus vectors","volume":"60","author":"Zheng","year":"2000","journal-title":"Cancer Res."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572814009205?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572814009205?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:23:44Z","timestamp":1759047824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572814009205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":39,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0165572814009205"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2014.10.002","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A dual vaccine against influenza & Alzheimer's disease failed to enhance anti-\u03b2-amyloid antibody responses in mice with pre-existing virus specific memory","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2014.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}